Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra (Q24289204)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra |
scientific article |
Statements
Should docetaxel be standard of care for patients with metastatic hormone-sensitive prostate cancer? Pro and contra (English)
0 references
August 2015
0 references
26
0 references
8
0 references
1660-7
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference